High-Cell-Density Culture to Produce Plasmid DNA for Gene Therapy in E. coli - How to produce Plasmid DNA in a high-cell-density culture. - BioPharm International

ADVERTISEMENT

High-Cell-Density Culture to Produce Plasmid DNA for Gene Therapy in E. coli

REFERENCES

1. Prazeres D, Ferreira G, Monteiro G, Cooney C, Cabral J. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy. Trends Biotechnol. 1999;17(4):169–74.

2. Prather KJ, Sagar S, Murphy J, Chartrain M. Industrial scale production of plasmid DNA for vaccine and gene therapy: Plasmid design, production and purification. Enzyme Microb Technol. 2003;33:865–83.

3. Schleef M, editor. Biotechnology. Volume 5a: Recombinant Proteins, Monoclonal antibodies and Therapeutic Genes. Hoboken, NJ: Wiley & Sons; 1999. p. 445–69.

4. Vogel FR, Sarver H. Nucleic acid vaccines. Clin Microbiol. 1995;8:406–10.

5. Robinson HL. DNA vaccines. Clin Microbiol Newslett. 2000;23:17–22.

6. Herweijer H, Wolf J. Progress and prospects: Naked DNA gene transfer and therapy. Gene therapy. 2003;10:453–8.

7. Chattergoon M, Boyer J, Weiner DB. Gene immunization: A new era in vaccines and immune therapeutics. FASEB. 1997 Aug;11(10):753–63.

8. O'Kennedy R, Ward J, Keshavarz E. Effects of fermentation strategy on the characteristics of plasmid DNA production. Biotecnol Appl Biochem. 2003 Feb;37 (Pt 1):83–90.

9. Kim B, Shuler M. Analysis of pBR322 replication kinetic and its dependency on growth rate. Biotechnol Bioeng. 1990;36:233–42.

10. Xu Z, LiuG, Cen P, Wong W. Factors influencing secretive production of human epidermal growth factor (hEGF) with recombinant E. coli K12. Bioprocess Biosyst Eng. 2000;23:669–74.

11. Miller G. Anal. Chem. 1959 31:426–8.

12. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979;7:1513–23.

13. Shiloach J, Fass R. Growing E. coli to high cell density—A historical perspective on method development. Biotechnol Adv. 2005;23:345–57.

14. Carnes A. Fermentation design for the manufacture of therapeutic plasmid DNA. BioProcess Int. 2005 Oct;3(9):36–44.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here